IBDEI0DO ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6538,2)
 ;;=^92164
 ;;^UTILITY(U,$J,358.3,6539,0)
 ;;=491.21^^44^524^1
 ;;^UTILITY(U,$J,358.3,6539,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6539,1,4,0)
 ;;=4^OBS CHR BRONCHITIS EXACERB
 ;;^UTILITY(U,$J,358.3,6539,1,5,0)
 ;;=5^491.21
 ;;^UTILITY(U,$J,358.3,6539,2)
 ;;=^330084
 ;;^UTILITY(U,$J,358.3,6540,0)
 ;;=585.1^^44^525^4
 ;;^UTILITY(U,$J,358.3,6540,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6540,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE I
 ;;^UTILITY(U,$J,358.3,6540,1,5,0)
 ;;=5^585.1
 ;;^UTILITY(U,$J,358.3,6540,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,6541,0)
 ;;=585.2^^44^525^5
 ;;^UTILITY(U,$J,358.3,6541,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6541,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE II
 ;;^UTILITY(U,$J,358.3,6541,1,5,0)
 ;;=5^585.2
 ;;^UTILITY(U,$J,358.3,6541,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,6542,0)
 ;;=585.3^^44^525^6
 ;;^UTILITY(U,$J,358.3,6542,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6542,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE III
 ;;^UTILITY(U,$J,358.3,6542,1,5,0)
 ;;=5^585.3
 ;;^UTILITY(U,$J,358.3,6542,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,6543,0)
 ;;=585.4^^44^525^7
 ;;^UTILITY(U,$J,358.3,6543,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6543,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE IV
 ;;^UTILITY(U,$J,358.3,6543,1,5,0)
 ;;=5^585.4
 ;;^UTILITY(U,$J,358.3,6543,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,6544,0)
 ;;=585.5^^44^525^8
 ;;^UTILITY(U,$J,358.3,6544,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6544,1,4,0)
 ;;=4^CHR KIDNEY DISEASE,STAGE V
 ;;^UTILITY(U,$J,358.3,6544,1,5,0)
 ;;=5^585.5
 ;;^UTILITY(U,$J,358.3,6544,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,6545,0)
 ;;=585.6^^44^525^9
 ;;^UTILITY(U,$J,358.3,6545,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6545,1,4,0)
 ;;=4^END STAGE RENAL DISEASE
 ;;^UTILITY(U,$J,358.3,6545,1,5,0)
 ;;=5^585.6
 ;;^UTILITY(U,$J,358.3,6545,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,6546,0)
 ;;=585.9^^44^525^3
 ;;^UTILITY(U,$J,358.3,6546,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6546,1,4,0)
 ;;=4^CHR KIDNEY DISEASE NOS
 ;;^UTILITY(U,$J,358.3,6546,1,5,0)
 ;;=5^585.9
 ;;^UTILITY(U,$J,358.3,6546,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,6547,0)
 ;;=584.9^^44^525^1
 ;;^UTILITY(U,$J,358.3,6547,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6547,1,4,0)
 ;;=4^ACUTE KIDNEY FAILURE NOS
 ;;^UTILITY(U,$J,358.3,6547,1,5,0)
 ;;=5^584.9
 ;;^UTILITY(U,$J,358.3,6547,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,6548,0)
 ;;=584.5^^44^525^2
 ;;^UTILITY(U,$J,358.3,6548,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6548,1,4,0)
 ;;=4^ACUTE KIDNEY FAILURE,TUBULAR NECROSIS
 ;;^UTILITY(U,$J,358.3,6548,1,5,0)
 ;;=5^584.5
 ;;^UTILITY(U,$J,358.3,6548,2)
 ;;=^338528
 ;;^UTILITY(U,$J,358.3,6549,0)
 ;;=583.81^^44^525^10
 ;;^UTILITY(U,$J,358.3,6549,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6549,1,4,0)
 ;;=4^NEPHRITIS AND NEPHROPATHY
 ;;^UTILITY(U,$J,358.3,6549,1,5,0)
 ;;=5^583.81
 ;;^UTILITY(U,$J,358.3,6549,2)
 ;;=^82243
 ;;^UTILITY(U,$J,358.3,6550,0)
 ;;=581.81^^44^525^11
 ;;^UTILITY(U,$J,358.3,6550,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6550,1,4,0)
 ;;=4^NEPHROTIC SYNDROME
 ;;^UTILITY(U,$J,358.3,6550,1,5,0)
 ;;=5^581.81
 ;;^UTILITY(U,$J,358.3,6550,2)
 ;;=^270346
 ;;^UTILITY(U,$J,358.3,6551,0)
 ;;=344.01^^44^526^1
 ;;^UTILITY(U,$J,358.3,6551,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6551,1,4,0)
 ;;=4^C1-C4 COMPLETE QUADRIPLEGIA
 ;;^UTILITY(U,$J,358.3,6551,1,5,0)
 ;;=5^344.01
 ;;^UTILITY(U,$J,358.3,6551,2)
 ;;=^303270
 ;;^UTILITY(U,$J,358.3,6552,0)
 ;;=344.02^^44^526^2
 ;;^UTILITY(U,$J,358.3,6552,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6552,1,4,0)
 ;;=4^C1-C4 INCOMPLETE QUADRIPLEGIA
